Exhibit 10.5


 


UNIT SUBSCRIPTION AGREEMENT


 


This UNIT SUBSCRIPTION AGREEMENT (this “Agreement”)
is made as of July 26, 2021, by and between Alpha Healthcare Acquisition Corp. III, a Delaware corporation (the “Company”),
having its principal place of business at 1177 Avenue of the Americas, 5th Floor, New York, New York 10036, and AHAC Sponsor
III LLC, a Delaware limited liability company (the “Subscriber”), having its principal place of business at 1177 Avenue
of the Americas, 5th Floor, New York, New York 10036.


 


WHEREAS, the Company desires to sell to the Subscriber
on a private placement basis (the “Placement”) an aggregate of 455,000 units (the “Initial Units”)
of the Company, and up to an additional 45,000 units (the “Additional Units” and, together with the Initial Units,
the “Units”) in the event that the underwriters’ 45-day over-allotment option (“Over-Allotment Option”)
is exercised in full or part, each Unit comprised of one share of Class A common stock of the Company, par value $0.0001 per share (“Common
Stock”) and one-fourth of one warrant, each whole warrant exercisable to purchase one share of Common Stock (“Warrant”),
for a purchase price of $10.00 per Unit. The shares of Common Stock underlying the Warrants are hereinafter referred to as the “Warrant
Shares”. The shares of Common Stock underlying the Units (excluding the Warrant Shares) are hereinafter referred to as
the “Placement Shares.” The Warrants underlying the Units are hereinafter referred to as the “Placement Warrants.” The
Units, Placement Shares, Placement Warrants and Warrant Shares, collectively, are hereinafter referred to as the “Securities.” Each
whole Placement Warrant is exercisable to purchase one share of Common Stock at an exercise price of $11.50 during the period commencing
30 days following the consummation of the Company’s initial business combination (the “Business Combination”),
as such term is defined in the registration statement in connection with the Company’s initial public offering of units (the “IPO”),
as amended at the time it becomes effective (the “Registration Statement”), and expiring on the fifth anniversary of
the consummation of the Business Combination; and


 


WHEREAS, the Subscriber wishes to purchase the
Initial Units and up to 45,000 Additional Units, and the Company wishes to accept such subscription from the Subscriber.


 


NOW, THEREFORE, in consideration of the premises
and the mutual covenants hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Company and the Subscriber hereby agree as follows:


 


1.
Agreement to Subscribe

 


1.1. Purchase and Issuance of the Initial Units.
Upon the terms and subject to the conditions of this Agreement, the Subscriber hereby agrees to purchase from the Company, and the Company
hereby agrees to sell to the Subscriber, on the Initial Closing Date (as defined below) the Initial Units in consideration of the payment
of the Purchase Price (as defined below). On the Initial Closing Date, the Company shall, at its option, deliver to the Subscriber the
certificates representing the Securities purchased or effect such delivery in book-entry form.


 


1.2. Purchase Price. The Subscriber shall pay $4,550,000
(the “Purchase Price”) by wire transfer of immediately available funds or by such other method as may be reasonably
acceptable to the Company, to the trust account (the “Trust Account”) at a financial institution to be chosen
by the Company, maintained by Continental Stock Transfer & Trust Company, acting as trustee (“Continental”), one
(1) business day prior to the date of effectiveness of the Registration Statement.


 


1.3. Initial Closing. The closing of the purchase
and sale of 455,000 Initial Units shall take place simultaneously with the closing of the IPO (the “Initial Closing Date”).
The closing of such Units shall take place at the offices of Goodwin Procter LLP, The New York Times Building, 620 Eighth Avenue, New
York, New York, 10018, or such other place as may be agreed upon by the parties hereto.


 


1.4. Purchase and Issuance of Additional Units.
Upon the terms and subject to the conditions of this Agreement, the Subscriber hereby agrees to purchase from the Company, and the Company
hereby agrees to sell to the Subscriber, on the Over-allotment Closing Date (as defined below) up to an aggregate of 45,000 Additional
Units in consideration of the payment of $10.00 per Additional Unit for a purchase price of up to $450,000 and in the same proportion
as the amount of the Over-Allotment Option is exercised. On the Over-Allotment Closing Date (as defined below), the Company shall, at
its option, deliver to the Subscriber the certificates representing the Securities purchased or effect such delivery in book-entry form.


 




     


     


    

 


1.5. Purchase Price. As payment in full for the
Additional Units being purchased under this Agreement, the Subscriber shall pay $10.00 per Additional Unit being purchased by wire transfer
of immediately available funds or by such other method as may be reasonably acceptable to the Company, to the Trust Account on the date
of the consummation of the closing of the over-allotment option, and concurrently with the consummation thereof, or on such earlier time
and date as may be mutually agreed by the Company and the Subscriber (each such date, an “Over-Allotment Closing Date”;
together with the Initial Closing Date, the “Closing Dates” and each, a “Closing Date”).


 


1.6. Over-Allotment Closing. The Over-Allotment
Closing Date shall take place at the offices of Goodwin Procter LLP, The New York Times Building, 620 Eighth Avenue, New York, New York,
10018, or such other place as may be agreed upon by the parties hereto.


 


1.7 Termination. This Agreement and each of the
obligations of the undersigned shall be null and void and without effect if the Initial Closing Date does not occur prior to December
31, 2021.


 


2. Representations and Warranties of the
Subscriber


 


The Subscriber represents and warrants to the Company
that:


 


2.1. No Government Recommendation or Approval. The
Subscriber understands that no federal or state agency has passed upon or made any recommendation or endorsement of the Company or the
Placement of the Securities.


 


2.2. Accredited Investor. The Subscriber represents
that it is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act of 1933,
as amended (the “Securities Act”), and acknowledges that the sale contemplated hereby is being made in reliance, among
other things, on a private placement exemption to “accredited investors” under the Securities Act and similar exemptions under
state law.


 


2.3.  Intent. The Subscriber is purchasing
the Securities solely for investment purposes, for the Subscriber’s own account (and/or for the account or benefit of its members
or affiliates, as permitted, pursuant to the terms of an agreement (the “Insider Letter”) to be entered into with respect
to the Securities between, among others, the Subscriber and the Company, as described in the Registration Statement), and not with
a view to the distribution thereof and the Subscriber has no present arrangement to sell the Securities to or through any person or entity
except as may be permitted under the Insider Letter. The Subscriber shall not engage in hedging transactions with regard to the Securities
unless in compliance with the Securities Act.


 


2.4.  Restrictions on Transfer. The Subscriber
acknowledges and understands the Units are being offered in a transaction not involving a public offering in the United States within
the meaning of the Securities Act. The Securities have not been registered under the Securities Act and, if in the future the Subscriber
decides to offer, resell, pledge or otherwise transfer the Securities, such Securities may be offered, resold, pledged or otherwise transferred
only (A) pursuant to an effective registration statement filed under the Securities Act, (B) pursuant to an exemption from registration
under Rule 144 promulgated under the Securities Act, if available, or (C) pursuant to any other available exemption from the registration
requirements of the Securities Act, and in each case in accordance with any applicable securities laws of any state or any other jurisdiction.
Notwithstanding the foregoing, the Subscriber acknowledges and understands the Securities are subject to transfer restrictions as described
in Section 8 hereof. The Subscriber agrees that if any transfer of its Securities or any interest therein is proposed to be made, as a
condition precedent to any such transfer, the Subscriber may be required to deliver to the Company an opinion of counsel satisfactory
to the Company with respect to such transfer. Absent registration or another available exemption from registration, the Subscriber agrees
it will not resell the Securities (unless otherwise permitted pursuant to the Insider Letter, as described in the Registration Statement). The
Subscriber further acknowledges that because the Company is a shell company, Rule 144 may not be available to the Subscriber for the resale
of the Securities until the one year anniversary following consummation of the initial Business Combination of the Company, despite technical
compliance with the requirements of Rule 144 and the release or waiver of any contractual transfer restrictions.


 




    2


     


    

 


2.5. Sophisticated Investor.


 


(i) The Subscriber is sophisticated in financial
matters and is able to evaluate the risks and benefits of the investment in the Securities.


 


(ii) The Subscriber is aware that an investment
in the Securities is highly speculative and subject to substantial risks because, among other things, the Securities are subject to transfer
restrictions and have not been registered under the Securities Act and therefore cannot be sold unless subsequently registered under the
Securities Act or an exemption from such registration is available. The Subscriber is able to bear the economic risk of its investment
in the Securities for an indefinite period of time.


 


2.6. Independent Investigation. The Subscriber,
in making the decision to purchase the Units, has relied upon an independent investigation of the Company and has not relied upon any
information or representations made by any third parties or upon any oral or written representations or assurances from the Company, its
officers, directors or employees or any other representatives or agents of the Company, other than as set forth in this Agreement. The
Subscriber is familiar with the business, operations and financial condition of the Company and has had an opportunity to ask questions
of, and receive answers from the Company’s officers and directors concerning the Company and the terms and conditions of the offering
of the Units and has had full access to such other information concerning the Company as the Subscriber has requested. The Subscriber
confirms that all documents that it has requested have been made available and that the Subscriber has been supplied with all of the additional
information concerning this investment which the Subscriber has requested.


 


2.7  Organization and Authority. The
Subscriber is duly organized, validly existing and in good standing under the laws of the State of Delaware and it possesses all requisite
power and authority necessary to carry out the transactions contemplated by this Agreement.


 


2.8. Authority. This Agreement has been validly
authorized, executed and delivered by the Subscriber and is a valid and binding agreement enforceable in accordance with its terms, subject
to the general principles of equity and to bankruptcy or other laws affecting the enforcement of creditors’ rights generally.


 


2.9. No Conflicts. The execution, delivery
and performance of this Agreement and the consummation by the Subscriber of the transactions contemplated hereby do not violate, conflict
with or constitute a default under (i) the Subscriber’s charter documents, (ii) any agreement or instrument to which the Subscriber
is a party or (iii) any law, statute, rule or regulation to which the Subscriber is subject, or any agreement, order, judgment or decree
to which the Subscriber is subject.


 


2.10. No Legal Advice from Company. The
Subscriber acknowledges it has had the opportunity to review this Agreement and the transactions contemplated by this Agreement and the
other agreements entered into between the parties hereto with the Subscriber’s own legal counsel and investment and tax advisors. Except
for any statements or representations of the Company made in this Agreement and the other agreements entered into between the parties
hereto, the Subscriber is relying solely on such counsel and advisors and not on any statements or representations of the Company or any
of its representatives or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated by
this Agreement or the securities laws of any jurisdiction.


 


2.11. Reliance on Representations and Warranties. The
Subscriber understands the Units are being offered and sold to the Subscriber in reliance on exemptions from the registration requirements
under the Securities Act, and analogous provisions in the laws and regulations of various states, and that the Company is relying upon
the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Subscriber set forth
in this Agreement in order to determine the applicability of such provisions.


 


2.12. No General Solicitation. The Subscriber
is not subscribing for the Units as a result of or subsequent to any general solicitation or general advertising, including but not limited
to any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over
television or radio, or presented at any seminar or meeting or in a registration statement with respect to the IPO filed with the Securities
and Exchange Commission (“SEC”).


 




    3


     


    

 


2.13. Legend. The Subscriber acknowledges
and agrees the certificates (if any) evidencing each of the Securities shall bear a restrictive legend (the “Legend”),
in form and substance substantially as set forth in Section 4 hereof.


 


3. Representations, Warranties and Covenants
of the Company


 


The Company represents and warrants to, and agrees
with, the Subscriber that:


 


3.1.  Valid Issuance of Capital Stock. The
total number of shares of all classes of capital stock which the Company has authority to issue is 100,000,000 shares of Class A Common
Stock, 10,000,000 shares of Class B Common Stock, $0.0001 par value per share (the “Class B Common Stock”), and 1,000,000
shares of preferred stock, $0.0001 par value per share (“Preferred Stock”). As of the date hereof, the Company has
issued and outstanding 4,312,500 shares of Class B Common Stock (of which up to 562,500 shares are subject to forfeiture as described
in the Registration Statement), no shares of Class A Common Stock and no shares of Preferred Stock. All of the issued shares of capital
stock of the Company have been duly authorized, validly issued, and are fully paid and non-assessable.


 


3.2.  Title to Securities. Upon issuance
in accordance with, and payment pursuant to, the terms hereof and that certain warrant agreement to be entered into between the Company
and Continental, as warrant agent (the “Warrant Agreement”), as the case may be, each of the Units, Placement Shares,
Placement Warrants and Warrant Shares will be duly and validly issued, fully paid and non-assessable. On the date of issuance of the Units,
the Warrant Shares shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the terms hereof
and the Warrant Agreement, as the case may be, the Subscriber will have or receive good title to the Units, Placement Shares and Placement
Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and pursuant
to the Insider Letter and (ii) transfer restrictions under federal and state securities laws.


 


3.3. Organization and Qualification. The Company
is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware and has the requisite
corporate power to own its properties and assets and to carry on its business as now being conducted.


 


3.4. Authorization; Enforcement. (i) The
Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and to issue the
Securities in accordance with the terms hereof, (ii) the execution, delivery and performance of this Agreement by the Company and
the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary corporate action, and no further
consent or authorization of the Company or its Board of Directors or stockholders is required, and (iii) this Agreement constitutes
valid and binding obligations of the Company enforceable against the Company in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or
affecting generally the enforcement of, creditors’ rights and remedies or by equitable principles of general application and except
as enforcement of rights to indemnity and contribution may be limited by federal and state securities laws or principles of public policy.


 


3.5. No Conflicts. The execution, delivery
and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby do not (i) result in
a violation of the Company’s certificate of incorporation or by-laws, (ii) conflict with, or constitute a default under any
agreement or instrument to which the Company is a party or (iii) any law statute, rule or regulation to which the Company is subject or
any agreement, order, judgment or decree to which the Company is subject. Other than any SEC or state securities filings which may be
required to be made by the Company subsequent to a Closing Date, and any registration statement which may be filed pursuant thereto, the
Company is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make
any filing or registration with, any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations
under this Agreement or issue the Units, Placement Shares, Placement Warrants or Warrant Shares in accordance with the terms hereof.


  




    4


     


    

 


4. Legends


 


4.1. Legend. The Company will issue the Units,
Placement Shares and Placement Warrants, and when issued, the Warrant Shares, purchased by the Subscriber in the name of the Subscriber.
The certificates (if any) evidencing Securities will bear the following Legend and appropriate “stop transfer” instructions:


 


“THE SECURITIES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS
AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL FOR THIS CORPORATION, IS AVAILABLE.”


 


“THE SECURITIES REPRESENTED BY
THIS CERTIFICATE ARE SUBJECT TO LOCKUP PURSUANT TO AN INSIDER LETTER BETWEEN, AMONG OTHERS, ALPHA HEALTHCARE ACQUISITION CORP. III AND
AHAC SPONSOR III LLC AND MAY ONLY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP PURSUANT
TO THE TERMS SET FORTH IN THE INSIDER LETTER.”


 


4.2.  Subscriber’s Compliance. Nothing
in this Section 4 shall affect in any way the Subscriber’s obligations and agreements to comply with all applicable securities
laws upon resale of the Securities.


 


4.3.  Company’s Refusal to Register
Transfer of the Securities. The Company shall refuse to register any transfer of the Securities, if in the sole judgment of the Company
such purported transfer would not be made (i) pursuant to an effective registration statement filed under the Securities Act, or
pursuant to an available exemption from the registration requirements of the Securities Act and (ii) in compliance herewith and with the
Insider Letter.


 


4.4.  Registration Rights. The Subscriber
will be entitled to certain registration rights which will be governed by a registration rights agreement (“Registration Rights
Agreement”) to be entered into between, among others, the Subscriber and the Company, on or prior to the effective date of the
Registration Statement. 


 


5. Waiver of Liquidation Distributions.


 


In connection with the Securities purchased pursuant
to this Agreement, the Subscriber hereby waives any and all right, title, interest or claim of any kind in or to any distributions of
the amounts in the Trust Account with respect to the Securities, whether (i) in connection with the exercise of redemption rights if the
Company consummates the Business Combination, (ii) in connection with any tender offer conducted by the Company prior to a Business Combination,
(iii) upon the Company’s redemption of shares of Common Stock sold in the Company’s IPO upon the Company’s failure to
timely complete the Business Combination or (iv) in connection with a stockholder vote to approve an amendment to the Company’s
amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to redeem 100%
of the Company’s public shares if the Company does not timely complete the Business Combination or (B) with respect to any other
provision relating to stockholders’ rights or pre-Business Combination activity. In the event the Subscriber purchases shares
of Common Stock in the IPO or in the aftermarket, any additional shares so purchased shall be eligible to receive the redemption value
of such shares of Common Stock upon the same terms offered to all other purchasers of Common Stock in the IPO in the event the Company
fails to consummate the Business Combination.


 


6. Terms of Placement Warrants. Each
Placement Warrant shall have the terms set forth in the Warrant Agreement.


 




    5


     


    

 


7. Rescission Right Waiver and Indemnification.


 


7.1. The Subscriber understands and acknowledges
an exemption from the registration requirements of the Securities Act requires there be no general solicitation of purchasers of the Units.
In this regard, if the IPO were deemed to be a general solicitation with respect to the Units, the offer and sale of such Units may not
be exempt from registration and, if not, the Subscriber may have a right to rescind its purchase of the Units. In order to facilitate
the completion of the Placement and in order to protect the Company, its stockholders and the amounts in the Trust Account from claims
that may adversely affect the Company or the interests of its stockholders, the Subscriber hereby agrees to waive, to the maximum extent
permitted by applicable law, any claims, right to sue or rights in law or arbitration, as the case may be, to seek rescission of its purchase
of the Units. The Subscriber acknowledges and agrees this waiver is being made in order to induce the Company to sell the Units to the
Subscriber. The Subscriber agrees the foregoing waiver of rescission rights shall apply to any and all known or unknown actions, causes
of action, suits, claims or proceedings (collectively, “Claims”) and related losses, costs, penalties, fees, liabilities
and damages, whether compensatory, consequential or exemplary, and expenses in connection therewith, including reasonable attorneys’
and expert witness fees and disbursements and all other expenses reasonably incurred in investigating, preparing or defending against
any Claims, whether pending or threatened, in connection with any present or future actual or asserted right to rescind the purchase of
the Units hereunder or relating to the purchase of the Units and the transactions contemplated hereby.


 


7.2. The Subscriber agrees not to seek recourse
against the Trust Account for any reason whatsoever in connection with its purchase of the Units or any Claim that may arise now or in
the future.


 


7.3. The Subscriber acknowledges and agrees that
the stockholders of the Company are and shall be third-party beneficiaries of this Section 7.


 


7.4. The Subscriber agrees that to the extent any
waiver of rights under this Section 7 is ineffective as a matter of law, the Subscriber has offered such waiver for the benefit of the
Company as an equitable right that shall survive any statutory disqualification or bar that applies to a legal right. The Subscriber acknowledges
the receipt and sufficiency of consideration received from the Company hereunder in this regard.


 


8. Terms of the Units and Placement Warrants


 


8.1. The Units and their component parts are substantially
identical to the units to be offered in the IPO except that: (i) the Units and component parts are subject to the transfer restrictions
described in the Insider Letter, (ii) the Placement Warrants will be non-redeemable if called for redemption pursuant to Section 6.1 of
the Warrant Agreement so long as they are held by the Subscriber (or any of its permitted transferees) and as otherwise provided in Section
5 herein, and may be exercisable on a “cashless” basis if held by the Subscriber or its permitted transferees, as further
described in the Warrant Agreement and (iii) the Units and component parts are being purchased pursuant to an exemption from the registration
requirements of the Securities Act and will become freely tradable only after the expiration of the lockup described above in clause (i)
and they are registered pursuant to the Registration Rights Agreement to be signed on or before the date of the Prospectus or an exemption
from registration is available.


 


8.2 The Subscriber agrees to vote the Placement
Shares in accordance with the terms of the Insider Letter and as otherwise described in the Registration Statement.


 


9. Governing Law; Jurisdiction; Waiver
of Jury Trial


 


This Agreement shall be governed by and construed
in accordance with the laws of the State of New York for agreements made and to be wholly performed within such state. The
parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions
contemplated hereby.


 




    6


     


    

 


10. Assignment; Entire Agreement; Amendment


 


10.1.  Assignment. Neither this Agreement
nor any rights hereunder may be assigned by any party to any other person other than by the Subscriber to a person agreeing to be bound
by the terms hereof, including the waiver contained in Section 7 hereof.


 


10.2.  Entire Agreement. This Agreement sets
forth the entire agreement and understanding between the parties as to the subject matter thereof and merges and supersedes all prior
discussions, agreements and understandings of any and every nature among them.


 


10.3. Amendment. Except as expressly provided
in this Agreement, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written
instrument signed by all of the parties hereto.


 


10.4.  Binding upon Successors. This Agreement
shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives, successors
and permitted assigns. 


 


11. Notices


 


11.1  Notices. Unless otherwise provided herein,
any notice or other communication to a party hereunder shall be sufficiently given if in writing and personally delivered or sent by facsimile
or other electronic transmission with copy sent in another manner herein provided or sent by courier (which for all purposes of this Agreement
shall include Federal Express or other recognized overnight courier) or mailed to said party by certified mail, return receipt requested,
at its address provided for herein or such other address as either may designate for itself in such notice to the other. Communications
shall be deemed to have been received when delivered personally, on the scheduled arrival date when sent by next day or 2nd-day courier
service, or if sent by facsimile upon receipt of confirmation of transmittal or, if sent by mail, then three days after deposit in the
mail. If given by electronic transmission, such notice shall be deemed to be delivered (a) if by electronic mail, when directed to
an electronic mail address at which the stockholder has consented to receive notice; (b) if by a posting on an electronic network
together with separate notice to the stockholder of such specific posting, upon the later of (1) such posting and (2) the giving
of such separate notice; and (c) if by any other form of electronic transmission, when directed to the stockholder.


 


12. Counterparts


 


This Agreement may be executed in one or more counterparts,
all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been
signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In
the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “pdf” format data file, such
signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the
same force and effect as if such facsimile or “.pdf” signature page were an original thereof.


 


13. Survival; Severability


 


13.1.  Survival. The representations, warranties,
covenants and agreements of the parties hereto shall survive the Closing Dates.


 


13.2. Severability. In the event that any provision
of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall
continue in full force and effect without said provision; provided that no such severability shall be effective if it materially changes
the economic benefit of this Agreement to any party.


 


14. Headings.


 


The titles and subtitles used in this Agreement
are used for convenience only and are not to be considered in construing or interpreting this Agreement.


 




    7


     


    

 


IN WITNESS WHEREOF, the parties hereto have executed
this Agreement to be effective as of the date first set forth above.


 


	 	COMPANY:
	 	 
	 	ALPHA HEALTHCARE ACQUISITION CORP. III
	 	 
	 	By: 	/s/ Patrick A. Sturgeon
	 	Name:  	 Patrick A. Sturgeon
	 	Title: 	Chief Financial Officer
	 	 
	 	SUBSCRIBER:
	 	 
	 	AHAC SPONSOR III LLC
	 	 
	 	By: 	/s/ Rajiv Shukla
	 	Name:   	Rajiv Shukla
	 	Title: 	Managing Member


 


[Unit Subscription Agreement with Sponsor]